Latest Insider Transactions at Vericel Corp (VCEL)
This section provides a real-time view of insider transactions for Vericel Corp (VCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vericel Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vericel Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 15
2021
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-80.52%
|
$510,000
$51.18 P/Share
|
|
Jul 15
2021
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.61%
|
$160,000
$16.25 P/Share
|
|
Jul 12
2021
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-78.05%
|
$1,060,000
$53.54 P/Share
|
|
Jul 12
2021
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+43.84%
|
$40,000
$2.65 P/Share
|
|
Jun 30
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,174
-16.72%
|
$61,048
$52.5 P/Share
|
|
Jun 30
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.29%
|
-
|
|
Jun 30
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
134
-0.34%
|
$7,638
$57.14 P/Share
|
|
Jun 30
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
694
+1.73%
|
$6,940
$10.95 P/Share
|
|
May 19
2021
|
Heidi Hagen |
BUY
Exercise of conversion of derivative security
|
Direct |
6,750
+22.78%
|
$33,750
$5.37 P/Share
|
|
May 14
2021
|
Paul K Wotton |
SELL
Open market or private sale
|
Direct |
5,000
-15.82%
|
$250,000
$50.52 P/Share
|
|
May 12
2021
|
Paul K Wotton |
SELL
Open market or private sale
|
Direct |
2,200
-6.51%
|
$105,600
$48.88 P/Share
|
|
May 11
2021
|
Paul K Wotton |
SELL
Open market or private sale
|
Direct |
13,448
-28.46%
|
$672,400
$50.11 P/Share
|
|
May 11
2021
|
Paul K Wotton |
BUY
Exercise of conversion of derivative security
|
Direct |
43,750
+31.66%
|
$612,500
$14.74 P/Share
|
|
Apr 28
2021
|
Steven C Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+33.33%
|
-
|
|
Apr 28
2021
|
Paul K Wotton |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+33.33%
|
-
|
|
Apr 28
2021
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+50.0%
|
-
|
|
Apr 28
2021
|
Heidi Hagen |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+33.33%
|
-
|
|
Apr 28
2021
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+33.33%
|
-
|
|
Apr 28
2021
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+15.7%
|
-
|
|
Apr 19
2021
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-7.94%
|
$2,320,000
$58.17 P/Share
|
|
Apr 19
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,563
+4.17%
|
$189,075
$25.8 P/Share
|
|
Mar 31
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,178
-29.45%
|
$64,790
$55.55 P/Share
|
|
Mar 31
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|
|
Mar 30
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
17,924
-15.36%
|
$914,124
$51.13 P/Share
|
|
Mar 30
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,438
+21.7%
|
$334,380
$10.95 P/Share
|
|
Mar 30
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.11%
|
$187,500
$25.8 P/Share
|
|
Mar 29
2021
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-5.17%
|
$2,040,000
$51.08 P/Share
|
|
Mar 19
2021
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+39.54%
|
$225,000
$45.2 P/Share
|
|
Mar 01
2021
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-4.26%
|
$1,920,000
$48.33 P/Share
|
|
Mar 01
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,355
+3.84%
|
$113,420
$4.2 P/Share
|
|
Feb 11
2021
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,516
-21.8%
|
$74,284
$49.23 P/Share
|
|
Feb 11
2021
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+33.48%
|
-
|
|
Feb 11
2021
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,267
-1.47%
|
$160,083
$49.23 P/Share
|
|
Feb 11
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.26%
|
-
|
|
Feb 11
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-2.91%
|
$36,162
$49.23 P/Share
|
|
Feb 11
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+6.02%
|
-
|
|
Feb 06
2021
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,078
-1.41%
|
$144,666
$47.18 P/Share
|
|
Feb 06
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,938
+3.08%
|
-
|
|
Feb 06
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
264
-1.1%
|
$12,408
$47.18 P/Share
|
|
Feb 06
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+2.64%
|
-
|
|
Feb 06
2021
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-20.53%
|
$41,924
$47.18 P/Share
|
|
Feb 06
2021
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+30.14%
|
-
|
|
Dec 21
2020
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-92.94%
|
$780,000
$26.28 P/Share
|
|
Dec 21
2020
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+48.17%
|
$60,000
$2.65 P/Share
|
|
Dec 21
2020
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,235
-40.09%
|
$630,110
$26.5 P/Share
|
|
Dec 21
2020
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,264
+38.64%
|
$432,640
$10.95 P/Share
|
|
Nov 23
2020
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
17,500
-35.5%
|
$402,500
$23.55 P/Share
|
|
Nov 23
2020
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+26.88%
|
$90,000
$3.25 P/Share
|